A detailed history of Ubs Group Ag transactions in Seer, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 443 shares of SEER stock, worth $1,072. This represents 0.0% of its overall portfolio holdings.

Number of Shares
443
Previous 455 2.64%
Holding current value
$1,072
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.59 - $2.07 $19 - $24
-12 Reduced 2.64%
443 $0
Q2 2024

Aug 13, 2024

SELL
$1.65 - $2.24 $88,626 - $120,317
-53,713 Reduced 99.16%
455 $0
Q1 2024

May 13, 2024

BUY
$1.54 - $2.09 $11,014 - $14,947
7,152 Added 15.21%
54,168 $102,000
Q4 2023

Feb 09, 2024

BUY
$1.47 - $2.22 $16,502 - $24,921
11,226 Added 31.37%
47,016 $91,000
Q3 2023

Nov 09, 2023

SELL
$2.18 - $5.52 $32,388 - $82,010
-14,857 Reduced 29.33%
35,790 $79,000
Q2 2023

Aug 11, 2023

BUY
$3.16 - $4.96 $92,417 - $145,060
29,246 Added 136.66%
50,647 $216,000
Q1 2023

May 12, 2023

SELL
$3.6 - $5.88 $22,172 - $36,214
-6,159 Reduced 22.35%
21,401 $82,000
Q4 2022

Feb 08, 2023

BUY
$5.03 - $8.58 $106,490 - $181,647
21,171 Added 331.37%
27,560 $159,000
Q3 2022

Nov 10, 2022

BUY
$7.7 - $13.31 $36,474 - $63,049
4,737 Added 286.74%
6,389 $49,000
Q2 2022

Aug 10, 2022

SELL
$6.72 - $16.07 $26,241 - $62,753
-3,905 Reduced 70.27%
1,652 $15,000
Q1 2022

May 16, 2022

SELL
$11.88 - $23.4 $188,238 - $370,773
-15,845 Reduced 74.04%
5,557 $85,000
Q4 2021

Feb 14, 2022

SELL
$21.08 - $38.51 $433,742 - $792,381
-20,576 Reduced 49.02%
21,402 $489,000
Q3 2021

Nov 15, 2021

BUY
$27.67 - $45.04 $1.15 Million - $1.88 Million
41,661 Added 13142.27%
41,978 $1.45 Million
Q2 2021

Aug 13, 2021

SELL
$28.75 - $56.92 $36,742 - $72,743
-1,278 Reduced 80.13%
317 $11,000
Q1 2021

May 12, 2021

BUY
$38.67 - $84.06 $61,678 - $134,075
1,595 New
1,595 $80,000

Others Institutions Holding SEER

About Seer, Inc.


  • Ticker SEER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,566,500
  • Market Cap $142M
  • Description
  • Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic res...
More about SEER
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.